Ghent, Belgium [November 22, 2019] – Indigo Diabetes NV, a medical device company creating next-gen sensors for diabetes healthcare, today announced it has received ISO 13485 certification from TÜV Süd for the Design and Development of Biomarker Sensing Devices and Services.
This certification confirms that Indigo’s quality management system and processes meets or exceeds the requirements of internationally agreed medical-device standards.
Indigo is committed to ensuring development and implementation of the highest quality products and services.
Indigo will perform regular audits to continuously ensure compliance and identify areas for improvement.